Developer docs
API playgroundTry for free, no card

Search company profiles

Estar Technologies

Full company profile

uuid000bm8a

Namestring
Estar Technologies
Company typeenum
Private
Founded yearint
1992
Short descriptiontext

Estar Technologies is a privately held Israeli biotechnology company founded in 1992, headquartered in Holon, Israel, that manufactures medical skincare products for the biotechnology and skincare sectors.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHolon, Israel
HQ citystring
Holon
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
medical skincare products, biotechnology manufacturing, dermatology formulations, therapeutic cosmetics, skincare biotech
Industry2 codes
1Dermocosmetics & Medical-Grade Skincare
CodeCRABAAAFPrimaryYes
2Laser & Energy-Based Dermatology
CodeHLAKACAFPrimaryNo
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Medical Skincare Products
No data
Cost components4 values
Supply Chain, Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Estar Technologies is a biotechnology company that manufactures medical skincare products. Founded in 1992 and based in Holon, Israel, the company operates in the dermatology / therapeutic skincare segment. Specific product formulations, technology platforms, and customer offerings are not detailed in the available source content.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Unable to extract product information from the available source content. The source page displayed only a verification loading screen with no substantive company or product information.

No data
Peers10 records
TypeDirect peer
Description

L'Oréal-owned medical-grade skincare brand built on biotech/pharmaceutical-grade active ingredients, sold largely through dermatologists and medical channels — directly comparable positioning to Estar's medical skincare focus.

TypeDirect peer
Description

Physician-dispensed medical skincare brand focused on clinically validated formulations for conditions such as hyperpigmentation and aging; comparable to Estar as a medical-grade skincare manufacturer targeting dermatology channels.

TypeDirect peer
Description

Galderma-owned medical-grade skincare brand specializing in procedure-supporting and rejuvenation products; comparable biotech-leaning medical skincare positioning to Estar.

TypeDirect peer
Description

AbbVie/Allergan-affiliated medical skincare line with a strong dermatology-channel presence and clinically positioned product portfolio; direct peer in the medical-grade skincare category.

TypeDirect peer
Description

Professional-grade skincare brand distributed through dermatologists and licensed aestheticians, focused on chemical peels and corrective products; comparable medical skincare manufacturer to Estar.

TypeBroad incumbent
Description

L'Oréal's flagship dermocosmetics brand offering dermatologist-recommended skincare across a broad portfolio; comparable medical-grade skincare category, though far larger and broader in scope than Estar.

TypeBroad incumbent
Description

NAOS-owned dermo-cosmetic brand with a strong biotech and dermatology heritage, sold via pharmacies globally; comparable medical skincare category but with significantly greater scale and geographic reach than Estar.

TypeDirect peer
Description

Medical-grade mineral-based skincare and sun protection brand sold primarily through dermatologists and plastic surgeons; comparable biotech/medical positioning and channel strategy to Estar.

TypeDirect peer
Description

Medical-grade skincare and sunscreen brand acquired by Colgate-Palmolive, distributed primarily through dermatology channels; comparable medical skincare manufacturer model.

TypeBroad incumbent
Description

Unilever-owned professional skincare brand distributed through licensed skin therapists and spas; overlaps with Estar in clinically positioned skincare, though broader in product range and channel mix.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Estar Technologies

Medical Skincare Productsestar-medical.com

Estar Technologies is a privately held Israeli biotechnology company founded in 1992, headquartered in Holon, Israel, that manufactures medical skincare products for the biotechnology and skincare sectors.

Estar Technologies firmographics

Firmographics
Name
Estar Technologies
Website
https://estar-medical.com
Company type
Private
Founded year
1992
Headcount range
11–50 employees
Short description
Estar Technologies is a privately held Israeli biotechnology company founded in 1992, headquartered in Holon, Israel, that manufactures medical skincare products for the biotechnology and skincare sectors.
Ownership category
akta.pro rank

Estar Technologies industry classification

Industry
Product category
Medical Skincare Products
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
akta.pro secondary industry
Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

  • Medical skincare products
  • Biotechnology manufacturing
  • Dermatology formulations
  • Therapeutic cosmetics
  • Skincare biotech

Where Estar Technologies is headquartered

Location

Headquarters

HQ city
Holon
HQ country
Israel
HQ region
Middle East

Markets served

Estar Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations

Estar Technologies product offering

Product offering

Core offering

Estar Technologies is a biotechnology company that manufactures medical skincare products. Founded in 1992 and based in Holon, Israel, the company operates in the dermatology / therapeutic skincare segment. Specific product formulations, technology platforms, and customer offerings are not detailed in the available source content.

Product overview

Unable to extract product information from the available source content. The source page displayed only a verification loading screen with no substantive company or product information.

Differentiator

Problem solved

Functional benefit

Companies that use Estar Technologies

Customer profile

Ideal customer profiles1 record

Estar Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Estar Technologies competitors and assessment

Company assessment

Direct peers

  • SkinCeuticals: L'Oréal-owned medical-grade skincare brand built on biotech/pharmaceutical-grade active ingredients, sold largely through dermatologists and medical channels — directly comparable positioning to Estar's medical skincare focus.
  • Obagi Medical: Physician-dispensed medical skincare brand focused on clinically validated formulations for conditions such as hyperpigmentation and aging; comparable to Estar as a medical-grade skincare manufacturer targeting dermatology channels.
  • Alastin Skincare: Galderma-owned medical-grade skincare brand specializing in procedure-supporting and rejuvenation products; comparable biotech-leaning medical skincare positioning to Estar.
  • SkinMedica: AbbVie/Allergan-affiliated medical skincare line with a strong dermatology-channel presence and clinically positioned product portfolio; direct peer in the medical-grade skincare category.
  • PCA Skin: Professional-grade skincare brand distributed through dermatologists and licensed aestheticians, focused on chemical peels and corrective products; comparable medical skincare manufacturer to Estar.
  • Colorescience: Medical-grade mineral-based skincare and sun protection brand sold primarily through dermatologists and plastic surgeons; comparable biotech/medical positioning and channel strategy to Estar.
  • EltaMD: Medical-grade skincare and sunscreen brand acquired by Colgate-Palmolive, distributed primarily through dermatology channels; comparable medical skincare manufacturer model.

Broad incumbents

  • La Roche-Posay: L'Oréal's flagship dermocosmetics brand offering dermatologist-recommended skincare across a broad portfolio; comparable medical-grade skincare category, though far larger and broader in scope than Estar.
  • Bioderma (NAOS): NAOS-owned dermo-cosmetic brand with a strong biotech and dermatology heritage, sold via pharmacies globally; comparable medical skincare category but with significantly greater scale and geographic reach than Estar.
  • Dermalogica: Unilever-owned professional skincare brand distributed through licensed skin therapists and spas; overlaps with Estar in clinically positioned skincare, though broader in product range and channel mix.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Estar Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Estar Technologies leadership team

Management profile

Number of profiles

Estar Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Estar Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Estar Technologies

What does Estar Technologies do?

Estar Technologies is a biotechnology company that manufactures medical skincare products. Founded in 1992 and based in Holon, Israel, the company operates in the dermatology / therapeutic skincare segment. Specific product formulations, technology platforms, and customer offerings are not detailed in the available source content.

When was Estar Technologies founded?

Estar Technologies was founded in 1992. It employs 11 to 50 people.

Where is Estar Technologies based?

Estar Technologies is headquartered in Holon, Israel, in the Middle East region.

Who are Estar Technologies's main competitors?

Direct peers on record are SkinCeuticals, Obagi Medical, Alastin Skincare, SkinMedica, PCA Skin, Colorescience and EltaMD. Broad incumbents are La Roche-Posay, Bioderma (NAOS) and Dermalogica.

Does Estar Technologies have an API?

No public API is recorded for Estar Technologies.

What industry is Estar Technologies in?

Estar Technologies's product category is Medical Skincare Products. Its primary akta.pro industry code is CRABAAAF, Dermocosmetics & Medical-Grade Skincare, with a secondary code of HLAKACAF, Laser & Energy-Based Dermatology. Its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMedical PRP Tubes Research:CAGR of 5.6% during the forecast periodQY Research Inc. announced the release of a 2025 market report forecasting the global Medical PRP Tubes market to grow from US$ 104 million in 2025 to US$ 159 million by 2032 at a CAGR of 6.3%. The report identifies key industry players including Estar Medical, Regen Lab SA, and Arthrex, noting that the top five manufacturers held approximately 54% of the revenue share in 2024. Growth is driven by increasing procedural volumes in orthopedics, sports medicine, and aesthetics, despite barriers such as inconsistent clinical evidence and reimbursement gaps.PR NewswireEstar Medical Announces Exclusive U.S. Distribution Agreement with Aesthetic Management Partners for the Cellenis® PRP Product lineEstar Medical has finalized an exclusive U.S. distribution agreement with Aesthetic Management Partners for its Cellenis® PRP product line, replacing previous distributor Eclipse. This strategic shift follows the termination of the Eclipse contract and the acquisition of Eclipse's brand assets by competitor Crown Laboratories, allowing Estar to maintain its market position under its global brand name.PR NewswireAesthetic Management Partners Announces Exclusive Distribution Agreement with Estar MedicalAesthetic Management Partners (AMP) has signed an exclusive long-term marketing and distribution agreement with Estar Medical to sell its PRP products in the US market. This partnership allows Estar Medical to launch its global Cellenis® brand in North America, leveraging AMP's established distribution network for regenerative medicine technologies.PR NewswireThe ITC Complaint Against Estar Medical in the U.S. is Withdrawn by RegenlabRegenlab USA LLC has withdrawn its U.S. International Trade Commission complaint against Estar Medical and Eclipse Medcorp after an ITC staff attorney agreed that Regenlab's patent claims were invalid and not infringed. The withdrawal follows a pattern of legal losses for Regenlab, including patent revocations in the UK and Europe, and findings that its CEO lacked credibility during investigations. Estar Medical continues to face antitrust claims from Regenlab in U.S. federal court, while Regenlab reportedly struggles with financial viability due to unpaid legal judgments.